Multiparametric MRI in the PSA Screening Era

被引:18
作者
George, Arvin K. [1 ]
Pinto, Peter A. [1 ]
Rais-Bahrami, Soroush [1 ]
机构
[1] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
LOCALIZED PROSTATE-CANCER; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; FUSION BIOPSY; TESLA; RESONANCE; CANDIDATES; ACCURACY; INVASION; THERAPY;
D O I
10.1155/2014/465816
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Prostate cancer remains significant public health concern amid growing controversies regarding prostate specific antigen (PSA) based screening. The utility of PSA has been brought into question, and alternative measures are investigated to remedy the overdetection of indolent disease and safeguard patients from the potential harms resulting from an elevated PSA. Multiparametric MRI of the prostate has shown promise in identifying patients at risk for clinically significant disease but its role within the current diagnostic and treatment paradigm remains in question. The current review focuses on recent applications of MRI in this pathway.
引用
收藏
页数:6
相关论文
共 43 条
  • [1] The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level-Can it rule out clinically significant prostate cancer?
    Abd-Alazeez, Mohamed
    Ahmed, Hashim U.
    Arya, Manit
    Charman, Susan C.
    Anastasiadis, Eleni
    Freeman, Alex
    Emberton, Mark
    Kirkham, Alex
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 45.e17 - 45.e22
  • [2] Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer
    Ahmed, Hashim U.
    Akin, Oguz
    Coleman, Jonathan A.
    Crane, Sarah
    Emberton, Mark
    Goldenberg, Larry
    Hricak, Hedvig
    Kattan, Mike W.
    Kurhanewicz, John
    Moore, Caroline M.
    Parker, Chris
    Polascik, Thomas J.
    Scardino, Peter
    van As, Nicholas
    Villers, Arnauld
    [J]. BJU INTERNATIONAL, 2012, 109 (11) : 1636 - 1647
  • [3] Betrouni N, 2013, IEEE ENG MED BIO, P370, DOI 10.1109/EMBC.2013.6609514
  • [4] Combined Ultrasmall Superparamagnetic Particles of Iron Oxide-Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer
    Birkhaeuser, Frederic D.
    Studer, Urs E.
    Froehlich, Johannes M.
    Triantafyllou, Maria
    Bains, Lauren J.
    Petralia, Giuseppe
    Vermathen, Peter
    Fleischmann, Achim
    Thoeny, Harriet C.
    [J]. EUROPEAN UROLOGY, 2013, 64 (06) : 953 - 960
  • [5] Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: The Lahey Clinic Medical Center experience and an international meta-analysis
    Cohen, Michael S.
    Hanley, Robert S.
    Kurteva, Teodora
    Ruthazer, Robin
    Silverman, Mark L.
    Sorcini, Andrea
    Hamawy, Karim
    Roth, Robert A.
    Tuerk, Ingolf
    Libertino, John A.
    [J]. EUROPEAN UROLOGY, 2008, 54 (02) : 371 - 381
  • [6] Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate
    de la Taille, A
    Antiphon, P
    Salomon, L
    Cherfan, M
    Porcher, R
    Hoznek, A
    Saint, F
    Vordos, D
    Cicco, A
    Yiou, R
    Zafrani, ES
    Chopin, D
    Abbou, CC
    [J]. UROLOGY, 2003, 61 (06) : 1181 - 1186
  • [7] Can Magnetic Resonance-Ultrasound Fusion Biopsy Improve Cancer Detection in Enlarged Prostates?
    Diaz, Annerleim Walton
    Hoang, Anthony N.
    Turkbey, Baris
    Hong, Cheng William
    Hong Truong
    Sterling, Todd
    Rais-Bahrami, Soroush
    Siddiqui, M. Minhaj
    Stamatakis, Lambros
    Vourganti, Srinivas
    Nix, Jeffrey
    Logan, Jennifer
    Harris, Colette
    Weintraub, Michael
    Chua, Celene
    Merino, Maria J.
    Choyke, Peter
    Wood, Bradford J.
    Pinto, Peter A.
    [J]. JOURNAL OF UROLOGY, 2013, 190 (06) : 2020 - 2025
  • [8] Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
    Edwards, Brenda K.
    Noone, Anne-Michelle
    Mariotto, Angela B.
    Simard, Edgar P.
    Boscoe, Francis P.
    Henley, S. Jane
    Jemal, Ahmedin
    Cho, Hyunsoon
    Anderson, Robert N.
    Kohler, Betsy A.
    Eheman, Christie R.
    Ward, Elizabeth M.
    [J]. CANCER, 2014, 120 (09) : 1290 - 1314
  • [9] Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection
    Haffner, Jeremie
    Lemaitre, Laurent
    Puech, Philippe
    Haber, Georges-Pascal
    Leroy, Xavier
    Jones, J. Stephen
    Villers, Arnauld
    [J]. BJU INTERNATIONAL, 2011, 108 (8B) : E171 - E178
  • [10] Magnetic Resonance Imaging Guided Prostate Biopsy in Men With Repeat Negative Biopsies and Increased Prostate Specific Antigen
    Hambrock, Thomas
    Somford, Diederik M.
    Hoeks, Caroline
    Bouwense, Stefan A. W.
    Huisman, Henkjan
    Yakar, Derya
    van Oort, Inge M.
    Witjes, J. Alfred
    Futterer, Jurgen J.
    Barentsz, Jelle O.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (02) : 520 - 527